Update on Ilara Health’s evaluation of ResAppDxResApp has continued commercial discussions with Ilara Health, a Kenya-based health technology company, to progress the launch of ResAppDx to medical facilities and clinics in Kenya.
Negotiations follow Ilara’s three-month evaluation of ResAppDx at five medical facilities in Kenya.
Discussions have advanced favourably, and the company expects that it will be able to provide shareholders with a more detailed update shortly.
if you go to Ilara health careers page their hiring 24 people .
Mostly Sales medical devices.
- Forums
- ASX - By Stock
- US Clinical- Individual digital cough sound
Update on Ilara Health’s evaluation of ResAppDxResApp has...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online